Jones R N
Tufts University School of Medicine, Boston, MA, USA. ronald-jones@jonesgr
Arch Pathol Lab Med. 2001 Oct;125(10):1285-9. doi: 10.5858/2001-125-1285-MPATAO.
To summarize the antimicrobial susceptibility testing results from the College of American Pathologists (CAP) Microbiology Surveys Program for 2000. Specifically, the frequency of tests used and the quantitative and qualitative (susceptibility category) accuracy were assessed.
The CAP Microbiology Surveys challenged subscribers in 2000 with 3 well-characterized organisms for antimicrobial susceptibility testing in pure culture. Each laboratory was to use the test method and reporting procedures routinely applied to patient samples. The strains were National Committee for Clinical Laboratory Standards (NCCLS) quality control organisms with precisely defined antimicrobial susceptibility patterns and reproducibility. Results reported by participants (2685-2979/sample) were graded for categorical accuracy and quantitative performance by comparing reported minimal inhibitory concentrations (microg/mL) or zone diameters (mm) against quality control ranges published by the NCCLS. The appropriateness of reported drugs was determined in the context of the type and anatomic location of the infection.
The tests most often used varied by the species of the organism and growth characteristics of the isolated strains. Nonfastidious, rapid-growing Surveys unknowns (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853) were most often tested with commercial systems (MicroScan, 42.0%-42.4%; Vitek, 41.5%-43.0%) or with the standardized disk diffusion method (12.8%-13.9%). In contrast, fastidious species, such as Streptococcus pneumoniae (ATCC 49619), were predominantly tested by Etest (40.3%), followed by disk diffusion (27.6%) and MicroScan (23.2%). Categorical accuracy was essentially equal between dilution (98.9%) and diffusion (99.0%) methods. Among the minimal inhibitory concentration methods used to test penicillin against S pneumoniae, Etest method quantitative accuracy (96.3%) was greater than that of MicroScan (92.4%). Quantitative accuracy was greatest for dilution minimal inhibitory concentration methods, with more than 90% of results within NCCLS quality control ranges for nearly all reported antimicrobials. Reevaluations of quality control ranges may be needed for 4 to 7 agents, depending on method. Reporting errors were also detected in 2 areas: (1) reporting results for drugs not active at the site of infection and (2) reporting results for drugs tested with suboptimal methods without published NCCLS interpretive criteria.
Antimicrobial susceptibility testing methods used in US laboratories were dominated by commercial products with relatively high accuracy (qualitative and quantitative). As available methods have become better suited to both fastidious and rapid-growing species, reporting errors have assumed a higher level of concern to the CAP Surveys in an effort to minimize prescription errors.
总结美国病理学家学会(CAP)2000年微生物学调查项目的抗菌药物敏感性试验结果。具体而言,评估了所使用试验的频率以及定量和定性(敏感性类别)准确性。
2000年,CAP微生物学调查向订阅者提供了3种特征明确的纯培养微生物进行抗菌药物敏感性试验。每个实验室应使用常规应用于患者样本的试验方法和报告程序。这些菌株是美国国家临床实验室标准委员会(NCCLS)的质量控制菌株,具有精确界定的抗菌药物敏感性模式和可重复性。通过将报告的最低抑菌浓度(μg/mL)或抑菌圈直径(mm)与NCCLS公布的质量控制范围进行比较,对参与者报告的结果(每个样本2685 - 2979个)进行分类准确性和定量性能分级。根据感染的类型和解剖位置确定所报告药物的适用性。
最常使用的试验因微生物种类和分离菌株的生长特性而异。非苛养、快速生长的调查未知菌(大肠埃希菌ATCC 25922、铜绿假单胞菌ATCC 27853)最常使用商业系统(MicroScan,42.0% - 42.4%;Vitek,41.5% - 43.0%)或标准化纸片扩散法(12.8% - 13.9%)进行检测。相比之下,苛养菌,如肺炎链球菌(ATCC 49619),主要通过Etest法检测(40.3%),其次是纸片扩散法(27.6%)和MicroScan法(23.2%)。稀释法(98.9%)和扩散法(99.0%)的分类准确性基本相当。在用于检测青霉素对肺炎链球菌的最低抑菌浓度方法中,Etest法的定量准确性(96.3%)高于MicroScan法(92.4%)。稀释最低抑菌浓度法的定量准确性最高,几乎所有报告的抗菌药物中,超过90%的结果在NCCLS质量控制范围内。根据方法不同,可能需要对4至7种药物重新评估质量控制范围。在两个方面也检测到报告错误:(1)报告在感染部位无活性的药物结果;(2)报告用未公布NCCLS解释标准的次优方法检测的药物结果。
美国实验室使用的抗菌药物敏感性试验方法以商业产品为主,准确性相对较高(定性和定量)。随着现有方法变得更适合苛养菌和快速生长菌,报告错误已成为CAP调查更关注的问题,以尽量减少处方错误。